aldosterone has been researched along with Non-alcoholic Fatty Liver Disease in 4 studies
Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although nonalcoholic fatty liver disease (NAFLD) is considered a cardiometabolic risk factor, no data exist on its prevalence and clinical relevance in AI." | 1.38 | Nonalcoholic fatty liver disease in subjects with adrenal incidentaloma. ( Alexandraki, K; Apostolopoulou, G; Chrousos, G; Kaltsas, G; Markou, A; Papanastasiou, L; Pappa, T; Piaditis, G; Samara, C; Tsiavos, V, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shim, S | 1 |
| Krishnaiah, M | 1 |
| Sankham, MR | 1 |
| Kim, I | 1 |
| Lee, Y | 1 |
| Shin, I | 1 |
| Oh, AR | 1 |
| Lee, HJ | 1 |
| Vu, TNL | 1 |
| Park, J | 1 |
| Choi, S | 1 |
| Park, S | 1 |
| Kwon, Y | 1 |
| Fang, S | 1 |
| Kim, DK | 1 |
| Schreier, B | 1 |
| Zipprich, A | 1 |
| Uhlenhaut, H | 1 |
| Gekle, M | 1 |
| Okamura, K | 1 |
| Okuda, T | 1 |
| Takamiya, Y | 1 |
| Shirai, K | 1 |
| Urata, H | 1 |
| Papanastasiou, L | 1 |
| Pappa, T | 1 |
| Samara, C | 1 |
| Apostolopoulou, G | 1 |
| Tsiavos, V | 1 |
| Markou, A | 1 |
| Alexandraki, K | 1 |
| Piaditis, G | 1 |
| Chrousos, G | 1 |
| Kaltsas, G | 1 |
1 review available for aldosterone and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Mineralocorticoid receptors in non-alcoholic fatty liver disease.
Topics: Aldosterone; Fibrosis; Homeostasis; Humans; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Rece | 2022 |
3 other studies available for aldosterone and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Discovery of (
Topics: Acrylates; Animals; Bile Acids and Salts; Esters; Intestines; Liver; Mice; Non-alcoholic Fatty Liver | 2022 |
High Fib4 index in patients with suspected NASH is associated with elevation of chymase-dependent angiotensin II-forming activity in circulating mononuclear leucocytes.
Topics: Aged; Aged, 80 and over; Aldosterone; Angiotensin II; Biomarkers; Blood Pressure; Chymases; Enzyme-L | 2019 |
Nonalcoholic fatty liver disease in subjects with adrenal incidentaloma.
Topics: Adrenal Gland Neoplasms; Aldosterone; Anthropometry; Body Mass Index; Case-Control Studies; Fatty Li | 2012 |